Current Mesothelioma Milataxel Drug studies

An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Milataxel
  URL:             clinicaltrials.gov

A recent study published in The Lancet  studied three groups of Mesothelioma patients on the effectiveness of Chemo.

Group 1 was given four cycles of mitomycin, vinblastine and cisplatin every three weeks

Group 2 was given one injection of vinorelbine every week for 12 weeks.

Both groups were also given Active symptom control treatments which can include:

steroids

painkillers

bronchodilators

palliative radiotherapy to control the cancer’s symptoms.

 
Group 3 only received the active symptom control treatments
Results:

At the time of the study, roughly 96 percent of patients in all three groups had died.

Patients in the chemotherapy group 2 that received vinorelbine, had a slightly better survival rate (37 percent) than the other two groups but, again, researchers said this was not statistically significant.

Quality-of-life scores

The study found that these symptoms were similar in all 3 groups:

physical functioning 

pain 

shortness of breath 

overall health status

Conclusion:

The study found that : “The addition of chemotherapy to ASC ( Active Symptom Control) offers no significant benefits in terms of overall survival or quality of life. However, exploratory analyses suggested that vinorelbine merits further investigation,” the authors concluded.

Source: www.nlm.nih.gov

Mesothelioma Treatment Options –

A patient newly diagnosed with Mesothelioma cancer is likely to be told their life expectancy is between  8 – 12 months . While this outlook is very grim new advances in modern Mesothelioma cancer treatment are being researched.

In January 2007, the Food and Drug Administration approved the MESOMARK assay to help monitor response to treatment in epithelial and bi-phasic malignant mesothelioma patients. Doctors using this test may be able to better monitor a patient’s progress.

Mesothelioma Treatments - What are your Options?

The 3 most common treatments are: 

Surgery - Removing the cancer

Chemotherapy - Uses drugs to fight off the cancer

Radiation Therapy - Uses high dose x-rays to kill the cancer cells

 

Often 1 or more of these treatment options are used together. If you have been diagnosed with Mesothelioma the sooner you start treatment the better your chances are. Talk to your doctor as soon as possible to begin a treatment plan .

For more detailed information on each of these mesothelioma treatment options please visit: Mesothelioma Web

The course of your treatment will depend on:

Location of the cancer

Stage of the cancer

Your age

Overall health

 

Mesothelioma Drug Studies

Results from recent studies confirm that Alimta®, Eli Lilly’s FDA-approved drug for mesothelioma, has clinical efficacy for the treatment of malignant pleural mesothelioma. Alimta Therapy is considered the chemotherapy standard of care for treatment of mesothelioma.

 ALIMTA® in combination with cisplatin is indicated for the treatment of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery.

 Read more about ALIMTA® at Alimta.com

 

 Mesothelioma Current Open Clinical trials:

  Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Cisplatin|Drug: Imatinib Mesylate|Drug: Pemetrexed
  More Information:  http://ClinicalTrials.gov/show/NCT00402766

 

Immunotoxin Therapy, Pemetrexed, and Cisplatin in Treating Patients With Malignant Pleural   Mesothelioma That Cannot Be Removed by Surgery
 Recruitment:     Recruiting
 Conditions:      Malignant Mesothelioma
 Interventions:   Drug: SS1(dsFv)-PE38 immunotoxin|Drug: cisplatin|Drug: pemetrexed disodium|Procedure:   immunoenzyme technique|Procedure: immunohistochemistry staining method|Procedure: pharmacological  study|Procedure: quality-of-life assessment
More Information: http://ClinicalTrials.gov/show/NCT00575770

Dasatinib in Resectable Malignant Pleural Mesothelioma
 Recruitment:     Recruiting
 Conditions:      Malignant Pleural Mesothelioma
 Interventions:   Drug: Dasatinib
 More Information: http://ClinicalTrials.gov/show/NCT00652574
Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers
  Recruitment:     Recruiting
  Conditions:      Lung Cancer|Mesothelioma
  Interventions:  
  More Information: http://ClinicalTrials.gov/show/NCT00188890

 

 Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: dasatinib|Procedure: immunoenzyme technique|Procedure: immunohistochemistry staining method|Procedure: laboratory biomarker analysis
  More information: http://ClinicalTrials.gov/show/NCT00509041

 

 Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: pazopanib hydrochloride|Procedure: laboratory biomarker analysis
 More information: http://ClinicalTrials.gov/show/NCT00459862

 
 Tomotherapy Treatment for Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Procedure: Tomotherapy
  More Information: http://ClinicalTrials.gov/show/NCT00469196

 
  Bortezomib in Treating Patients With Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: bortezomib|Procedure: quality-of-life assessment
  more Information: http://ClinicalTrials.gov/show/NCT00513877

 
AZD2171 in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: cediranib|Procedure: laboratory biomarker analysis
  More Information: http://ClinicalTrials.gov/show/NCT00309946

 

Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: bortezomib|Drug: cisplatin
 More Information: http://ClinicalTrials.gov/show/NCT00458913

 
Study of CBP501 + Pemetrexed + Cisplatin in Patients With Solid Tumors (Phase I) and Patients With Malignant Pleural Mesothelioma (Phase II)
  Recruitment:     Recruiting
  Conditions:      Malignant Pleural Mesothelioma|MPM|Solid Tumors
  Interventions:   Drug: pemetrexed, cisplatin and CBP501|Drug: pemetrexed and cisplatin
  More Information: http://ClinicalTrials.gov/show/NCT00700336

 

Pharmacokinetic, Safety, and Efficacy Effects of Oral LBH589 on Dextromethorphan in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Carcinoma, Non-Small-Cell Lung|Mesothelioma
  Interventions:   Drug: LBH 589
  More Information: http://ClinicalTrials.gov/show/NCT00535951

 
Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: cisplatin|Drug: pemetrexed disodium|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: laboratory biomarker analysis|Procedure: neoadjuvant therapy|Procedure: quality-of-life assessment|Procedure: radiation therapy
  URL:             http://ClinicalTrials.gov/show/NCT00334594

 
  Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: antineoplaston A10|Drug: antineoplaston AS2-1
  URL:             http://ClinicalTrials.gov/show/NCT00003508

 
  Dendritic Cell-Based Immunotherapy in Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Pleural Mesothelioma
  Interventions:   Biological: tumor lysate-loaded autologous dendritic cells
  URL:             http://ClinicalTrials.gov/show/NCT00280982

 
Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, or Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Esophageal Cancer|Lung Cancer|Malignant Mesothelioma
  Interventions:   Procedure: DNA methylation analysis|Procedure: bronchoalveolar lavage|Procedure: bronchoscopy|Procedure: endoscopic biopsy|Procedure: gene expression analysis|Procedure: needle biopsy
  URL:             http://ClinicalTrials.gov/show/NCT00447447

 
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Procedure: adjuvant therapy|Procedure: chemotherapy|Procedure: conventional surgery|Procedure: neoadjuvant therapy|Procedure: radiation therapy
  URL:             http://ClinicalTrials.gov/show/NCT00253409

 

 Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: cisplatin|Drug: pemetrexed disodium|Drug: vitamin B12|Procedure: gene expression analysis|Procedure: laboratory biomarker analysis|Procedure: pharmacological study
  URL:             http://ClinicalTrials.gov/show/NCT00541073

 
 Cisplatin, Pemetrexed and Bevacizumab for Untreated Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: bevacizumab|Drug: cisplatin|Drug: pemetrexed
  URL:             http://ClinicalTrials.gov/show/NCT00295503

 

An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Vinorelbine|Drug: Vandetanib
  URL:             http://ClinicalTrials.gov/show/NCT00597116

 

  Study of Carboplatin and Vinorelbine in Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Pleural Mesothelioma
  Interventions:   Drug: Carboplatin and Vinorelbine
  URL:             http://ClinicalTrials.gov/show/NCT00272558

 
Vorinostat (MK0683, SAHA) Versus Placebo in Advanced Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma|Lung Cancer
  Interventions:   Drug: Suberoylanilide Hydroxamic Acid (SAHA)|Drug: Placebo (unspecified)
  URL:             http://ClinicalTrials.gov/show/NCT00128102

 
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: NGR-hTNF
  URL:             http://ClinicalTrials.gov/show/NCT00484276

 
 An Efficacy Study of Milataxel (TL139) Administered Orally for Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Milataxel
  URL:             http://ClinicalTrials.gov/show/NCT00685204

 
Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Pleural Mesothelioma
  Interventions:   Procedure: Extrapleural pneumonectomy (EPP)|Drug: cisplatin|Drug: gemcitabine|Drug: amifostine|Drug: sodium thiosulfate
  URL:             http://ClinicalTrials.gov/show/NCT00571298

 

  Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Malignant Mesothelioma
  Interventions:   Drug: Valproate plus doxorubicin
  URL:             http://ClinicalTrials.gov/show/NCT00634205

 

 

Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
  Recruitment:     Recruiting
  Conditions:      Leukemia|Lung Cancer|Malignant Mesothelioma|Myelodysplastic Syndromes|Peritoneal Cavity Cancer
  Interventions:   Drug: WT-1 analog peptide vaccine|Drug: incomplete Freund’s adjuvant|Drug: sargramostim|Procedure: flow cytometry|Procedure: immunoenzyme technique|Procedure: polymerase chain reaction
  URL:             http://ClinicalTrials.gov/show/NCT00398138

 

Decitabine and FR901228 in Treating Patients With Advanced Lung Cancer, Esophageal Cancer, Pleural Mesothelioma, or Lung Metastases
  Recruitment:     Recruiting
  Conditions:      Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer
  Interventions:   Drug: celecoxib|Drug: decitabine|Drug: romidepsin
  URL:             http://ClinicalTrials.gov/show/NCT00041158

 

  Mesothelioma Avastin Plus Pemetrexed-Cisplatin Study
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Standard Chemotherapy (Pemetrexed and Cisplatin)|Drug: Standard Chemotherapy (Pemetrexed and Cisplatin) + Bevacizumab
  URL:             http://ClinicalTrials.gov/show/NCT00651456

 
 Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen
  Recruitment:     Recruiting
  Conditions:      Non-Small Cell Lung Cancer|Mesothelioma|Lung Neoplasms
  Interventions:   Drug: pemetrexed
  URL:             http://ClinicalTrials.gov/show/NCT00316225

 
  Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide
  Recruitment:     Recruiting
  Conditions:      Soft Tissue Sarcoma|Mesothelioma
  Interventions:   Drug: Azacitidine In Combination With Temozolomide
  URL:             http://ClinicalTrials.gov/show/NCT00629343

 
 Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With MPM
  Recruitment:     Recruiting
  Conditions:      Mesothelioma
  Interventions:   Drug: Carboplatin, Bevacizumab and Pemetrexed
  URL:             http://ClinicalTrials.gov/show/NCT00604461

 
Study of Safety and Tolerability of Intravenous CRS-207 in Adults With Selected Advanced Solid Tumors Who Have Failed or Who Are Not Candidates for Standard Treatment
  Recruitment:     Recruiting
  Conditions:      Malignant Epithelial Mesothelioma|Adenocarcinoma of the Pancreas|Carcinoma, Non-Small-Cell Lung|Adenocarcinoma of the Ovaries
  Interventions:   Biological: CRS-207, Live-attenuated Listeria monocytogenes expressing human Mesothelin
  URL:             http://ClinicalTrials.gov/show/NCT00585845

 

FR901228 and Flavopiridol in Treating Patients With Advanced Lung, Esophageal, or Pleural Cancer
  Recruitment:     Recruiting
  Conditions:      Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer
  Interventions:   Drug: alvocidib|Drug: romidepsin
  URL:             http://ClinicalTrials.gov/show/NCT00098644

 
Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
  Recruitment:     Recruiting
  Conditions:      Breast Cancer|Colorectal Cancer|Lung Cancer|Malignant Mesothelioma|Prostate Cancer|Psychosocial Effects/Treatment|Quality of Life|Thymoma and Thymic Carcinoma
  Interventions:   Procedure: educational intervention
  URL:             http://ClinicalTrials.gov/show/NCT00372840

 
 Gene Therapy for Pleural Malignancies
  Recruitment:     Recruiting
  Conditions:      Pleural Mesothelioma|Metastatic Pleural Effusions
  Interventions:   Gene Transfer: BG00001 (adenoviral-mediated interferon-beta)
  URL:             http://ClinicalTrials.gov/show/NCT00299962

 
A Study To Find the Best Dose of SU011248 When Given With Pemetrexed, Pemetrexed and Cisplatin Or Pemetrexed and Carboplatin in Patients With Advanced Solid Tumors
  Recruitment:     Recruiting
  Conditions:      Non-Small Cell Lung Cancer|Mesothelioma|Neoplasms
  Interventions:   Drug: Sunitinib, Pemetrexed, Cisplatin, Carboplatin
  URL:             http://ClinicalTrials.gov/show/NCT00528619

 

Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis
  Recruitment:     Recruiting
  Conditions:      Stomach Neoplasms|Colorectal Neoplasms|Neoplasm Metastasis|Mesothelioma
  Interventions:   Procedure: cytoreductive surgery|Procedure: intraoperative peritoneal hyperthermic chemotherapy with cisplatin and mitomycin
  URL:             http://ClinicalTrials.gov/show/NCT00454519

 

  Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
  Recruitment:     Recruiting
  Conditions:      Cancer
  Interventions:   Drug: fentanyl sublingual spray|Procedure: questionnaire administration
  URL:             http://ClinicalTrials.gov/show/NCT00538850

 

 Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
  Recruitment:     Recruiting
  Conditions:      Solid Tumor|Lymphoma
  Interventions:   Drug: belinostat
  URL:             http://ClinicalTrials.gov/show/NCT00413075

 
Electronic Tool to Record Cancer Symptoms in Patients With Advanced Cancer Receiving Palliative Care
  Recruitment:     Recruiting
  Conditions:      Cancer
  Interventions:   Procedure: cognitive assessment|Procedure: counseling|Procedure: fatigue assessment and management|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessment
  URL:             http://ClinicalTrials.gov/show/NCT00477919

 
  Rapamycin With Grapefruit Juice for Advanced Malignancies
  Recruitment:     Recruiting
  Conditions:      Tumors|Neoplasm Metastasis
  Interventions:   Drug: Rapamycin (sirolimus)|Other: Grapefruit Juice
  URL:             http://ClinicalTrials.gov/show/NCT00375245

 
  Phase I Study of OSI-930 and Erlotinib in Cancer Tumors
  Recruitment:     Recruiting
  Conditions:      Advanced Solid Tumors
  Interventions:   Drug: OSI-930 and erlotinib
  URL:             http://ClinicalTrials.gov/show/NCT00603356

 
An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation
  Recruitment:     Recruiting
  Conditions:      Ovarian Neoplasms|Colorectal Neoplasms|Melanoma|Small Cell Lung Cancer|Liposarcoma
  Interventions:   Radiation: Ionizing radiation (IR) therapy|Radiation: Ionizing radiation (IR)
  URL:             http://ClinicalTrials.gov/show/NCT00132704

 
  Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer
  Recruitment:     Recruiting
  Conditions:      Cancer
  Interventions:   Drug: Pemetrexed|Drug: Bevacizumab
  URL:             http://ClinicalTrials.gov/show/NCT00222729

 

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
  Recruitment:     Recruiting
  Conditions:      Peritoneal Neoplasms|Retroperitoneal Neoplasms|Gastrointestinal Neoplasms|Adenocarcinoma|Neuroblastoma|Ovarian Neoplasms|Sarcoma|Adrenocortical Carcinoma|Wilms Tumor|Rhabdomyosarcoma|Desmoplastic Small Round Cell Tumor
  Interventions:   Drug: Cisplatin
  URL:             http://ClinicalTrials.gov/show/NCT00436657

 
  Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
  Recruitment:     Recruiting
  Conditions:      Cancer of the Head and Neck
  Interventions:   Drug: Gemcitabine|Drug: Oxaliplatin
  URL:             http://ClinicalTrials.gov/show/NCT00256295

 

Mesothelioma Settlements: Helping You Get Your Life Back on Track

 

Mesothelioma settlements are a reality. If you suffer from mesothelioma, running after a settlement is your best option. What options are available to you and your family?

 

Asbestos Cancer

 

Mesothelioma is also known as asbestos cancer. This is considered a rare form of cancer that affects the membrane covering some internal organs such as the lungs and abdominal cavity. Although it is rare, it is considered quite controversial. This is because the disease is triggered by exposure to asbestos, a mineral that has been in use in various industrial applications for years. Workers and family members of workers who handle asbestos may breathe or ingest asbestos. Once asbestos settles in the organ membrane, it can stay there for a couple of decades before cancer develops.

 

It has been determined that many industry owners are aware of the dangers of asbestos. Some of these industries have not taken the necessary precautions to protect their workers and the public in general. When someone develops mesothelioma, it may be due to the negligence of a company that uses asbestos. It is therefore within a mesothelioma sufferer’s rights to seek compensation from a negligent company.

 

Going after mesothelioma settlements are optional. For many patients however, seeking a settlement has almost become a necessity. Suffering from mesothelioma does not just result in extreme physical pain. It can also put a family into a lot of financial stress. A settlement therefore is intended, first and foremost, to cover the medical bills of sufferers. A settlement will also cover income lost due to illness.

 

Settlement Options

 

You can choose to seek compensation through a trial. Trials however may take a lot of time and may also result in more emotional trauma for sufferers and their families. There is also the problem of a prescription period which limits a patient’s time frame to stake a claim. One good alternative to a trial would be to settle out of court. Both parties may agree to a suitable amount of compensation, thus removing the need for a trial.

 

Settlement figures aren’t uniform. Some patients may only receive a couple of thousands of dollars. Others however may receive millions. The differences in figures depend on a couple of factors. These may include state laws, case merits and extent and duration of illness and suffering. In a lot of cases, the skill of your lawyer is also a factor that can affect settlement details.

 

Hiring a Lawyer

 

Mesothelioma is a serious condition. It can also be a very complicated one. This is why sufferers who seek a settlement need expert lawyers to handle their cases. Aside from sufficient knowledge about local laws, a mesothelioma lawyer also needs to have some knowledge about the disease itself. Extensive knowledge is what lawyers need to come up with convincing evidence and arguments related to client asbestos exposure.

 

Mesothelioma settlements are not myths. If you suffer from the disease, you too can hope for a good settlement. It is crucial to realize though that finding an expert lawyer is a necessity.

 

Mesothelioma Prognosis: Knowing Your Chances

 

Some mesothelioma patients want to know about mesothelioma prognosis. They may have their own personal valid reasons for wanting to know their chances of survival or getting better. If you are a mesothelioma patient interested in the same thing, then you have the right to know. Do keep in mind though that there are various prognosis sources. Here are some important points you should consider when reading about asbestos cancer prognosis. 

 

Prognosis Data

 

The first thing you should understand is where prognosis data comes from. Real prognosis information is based form statistical data. Researchers look into different mesothelioma cases through clinical studies to get average figures. This may mean that genuine prognosis information may be true for a large number of patients. This does not mean though that the information is always true.

Asbestos cancer cases can be unique. This is because a lot of different factors can affect mesothelioma. Some of these include your overall health, treatments taken, time when treatment began, mesothelioma type and severity of the condition. It is therefore important not to view prognosis information as absolutely true in your case.

 

Difficulties with Prognosis

 

It may be difficult to arrive at statistical or personal mesothelioma prognosis. This is because mesothelioma itself is not like many other forms of cancer. The condition is rare. Asbestos exposure, which is the primary risk factor linked to this condition is not always experienced by a lot of people. Those who also have the condition may not immediately seek doctors’ assistance for diagnosis and treatment. The symptoms do not obviously point to the condition and may even mimic the symptoms of other diseases.

 

Statistical Information

 

So what do the statistical figures say? Since patients are often diagnosed late, the prognosis for many patients is not good. A lot of patients are told that they can expect to live for only less than a year. Again, there are exceptions to this prognosis. There have been personal accounts of patients who have survived for more than five years. Some even live up to ten years after diagnosis.

 

Diagnosis

 

Like other forms of cancer, early mesothelioma diagnosis is important. Early diagnosis means early treatment and higher chances of survival. Since early diagnosis is not often made due to the lack of unique symptoms, you may not even think that a doctor’s visit is necessary. Your only clue that may suggest that you may need medical monitoring is asbestos exposure. This is only true however for individuals who work closely with asbestos. Patients who do not handle asbestos on a regular basis may not even remember or know that they have been exposed to asbestos.

 

Treatment

 

Treatment is one factor that can affect individual prognosis. Depending on your overall health, the stage of your disease and your doctor’s evaluation, you may have to undergo one or two cancer treatment methods. Like other forms of cancer, mesothelioma may be treated through chemotherapy, surgery or radiation therapy.

 

Mesothelioma prognosis is definitely never definite. Although prognosis information can provide you with valuable insight about the disease, there is no reason to believe that you absolutely have no hope of surviving beyond a year.

 

 

 

 

 

These Recent Mesothelioma cases will help give you an idea of the settlement amount that can be awarded for victims and their families.

$8 million Mesothelioma verdict against Exxon Mobil - 2001

A jury awarded a verdict of $8 million in favor of an an insulator contractor who worked around boilers at an oil refiinery in California. Exxon Mobil owned the refinery.

$2.5 Million Mesothelioma  lawsuit verdict - 2006

A retired machinist and his wife sued John Crane, Inc and Thorpe Insulation Company in a product liability suit. The defendants were negligent and failed to warn about defects in their products, which contained asbestos .

$659,000 Mesothelioma Lawsuit against Dowman Products Inc - 2004

A flooring installer of Oregon installed floors in hundreds of homes before he fell ill with asbestos pleural disease which then turned into Malignant mesothelioma. A jury found the flooring products manufactor liable and awarded over $659,000 . Sadly Mr. Nagl died 5 months after the trial ended, our hearts go out to his family.

 $33.7 million Asbestos Verdict - California

A San Francisco jury returned the largest asbestos verdict in California, $33.7 million, in favor of a Navy electrician and his wife. The electrician had developed mesothelioma from his occupational exposure to asbestos. He was awarded $22.7 million in economic and non–economic damages. His wife was awarded $11 million for loss of consortium. The defendant, Foster Wheeler Corporation, designed, manufactured and supplied marine boilers with asbestos–containing components including refractory block insulation, roving material, and gaskets.

$1.9 Million awarded in 2005

A California jury awarded over $1.9 million to a 71–year–old retired sheet metal worker who developed peritoneal mesothelioma from his prior on–the–job exposure to asbestos.

The defendant, Duro Dyne Corporation, is a former manufacturer and distributor of asbestos–containing flex HVAC duct connectors and duct sealer used for sheet metal duct connections. Mr. Garcia worked with Duro Dyne Corporation’s asbestos–containing sheet metal products throughout his 48–year career.

2005 Jury returned a verdict of over $8.6 million

A 60 year old Navy machinist and engineering officer was exposed to asbestos in products made by the defendants, John Crane, Inc. and Metalclad Insulation Corp., and developed pleural mesothelioma.

 2003 $2.9 million awarded to retired electrician diagnosed with Pleural Mesothelioma

the 74 year old retired electrician had worked with asbestos–containing phenolic plastic compounds and asbestos–containing parts on electrical equipment. Rockwell Automation, was held liable for the defective products and negligence of its Allen Bradley division and a former division, Rostone Corporation.

Rostone Corporation developed, manufactured and sold asbestos–containing phenolic plastic compounds and molded asbestos–containing parts for many of the major electrical equipment manufacturers. Allen Bradley also manufactured and sold asbestos–containing electrical equipment.

$4.4 million Verdict awarded to a steam fitter - 2001

A jury awarded $4.4 million in damages to a steam fitter diagnosed with mesothelioma. The defendant, John Crane, Inc., manufactured asbestos pump and valve packing and gaskets that the steamfitter used at a power plant during the 1950s and 1960s.

Jury awarded over $1 million to two children

Sadly their mother died from abdominal mesothelioma which was  caused by her exposure to asbestos when she smoked Kent Micronite asbestos–filtered cigarettes from 1953–1956

$4.6 million Mesothelioma Verdict - 2000

Jury awarded over $4.6 million to a former Navy seaman afflicted with malignant mesothelioma caused by his occupational exposure to asbestos.

$4.5 million to an insulator

 The insulator worked in refineries, power plants and shipyards during the 1960s and 1970s developed pleural mesothelioma from his exposure to asbestos. His award included $96,500 for medical expenses; $857,546 lost earnings; and $3,500,000 for pain and suffering.

 Machinist awarded $4.5 million

During his work as a machinist he developed  Pleural Mesothelioma as the result of his exposure to asbestos. $1 million went to his wife for her loss of consortium claim.

Source: Mesothelioma Verdicts

Choosing the right Attorney can make or break your case

If you or a loved one has been stricken with Mesothelioma Cancer it was most likely caused by exposure to asbestos and you will be in need of a highly skilled attorney to help you seek damages.

You should be looking for an attorney who specifically deals with Mesothelioma lawsuits. Any dedicated lawyer would be just as likely to commit time and effort on your case but to get the most cash you can for your lawsuit I would recommend selecting an attorney who has tried, settled and won several Mesothelioma Asbestos lawsuits.

• Your attorney should already have some knowledge about this rare cancer . An inexperienced lawyer may not even know that such a condition exists and may have to take a lot of time on research alone. An experienced Mesothelioma attorney would know right away the effects of asbestos exposure and would know how to empathize with your situation and get you the cash settlement you deserve.

• Not every patient is aware that they have been exposed to asbestos. If you do not know how you got Mesothelioma, a good attorney can help you trace the possible points of asbestos exposure. This is not an easy task for an average attorney. Did you know it can take up 30 years after asbestos exposure for symptoms to appear? A skilled Mesothelioma attorney will be able to research and pin point when you got exposed.

• A good lawyer knows that time is of the essence. Various states have limits to the period of time that you can make a claim after diagnosis. An expert attorney can act quickly to help you win your case.

. This is a rare cancer most commonly caused by unknowing exposure to asbestos. If you want to make things easier on you and your family, an attorney specifically dealing with Mesothelioma cases is the firm to look for.

Important questions to ask a Mesothelioma Attorney:

How long has your law firm been specializing in Mesothelioma cases?

How many cases has your firm taken to trial? How many verdicts won / lost?

How many cases has your law firm settled?

What is the average cash settlement your clients receive?

What happens if you don’t win my case, will your law firm appeal the decision? How many appeals has your firm won / lost?

Will I be working with a lawyer at your law firm or will you refer my case to another firm?

What is the average time frame it takes your law firm to win/settle a case?

While an attorney will not be able to give you a specific date, they should be able to provide with you a general idea on how long it will take to win your case.

You have one chance to bring a lawsuit against the company that exposed you to asbestos ,so it’s important to choose an attorney that will work the hardest to win your case.

Ask for references and check them thoroughly, only select a law firm that has a proven track record of winning multiple Mesothelioma Cancer cases.

For more information please visit the:
Mesothelioma Resource Guide

Mesothelioma litigation is an option for mesothelioma patients. Litigation however is not an easy path to consider. Before you choose to sue, there are a couple of crucial facts that you should be aware of.

 

You have the right to sue.

 

It may not be your fault that you are sick. Mesothelioma is a type of cancer that results from exposure to asbestos fibers. Like any average individual, you probably wouldn’t consider exposing yourself to asbestos of your own free will. You may have been exposed to asbestos due to your work or due to a family member who works with asbestos.

 

So why should you sue if you find out you have mesothelioma? Companies that hire individuals to work on asbestos would typically know that there are certain dangers involved in handling the mineral. Company safety rules should therefore be strictly implemented to prevent asbestos exposure. If you develop mesothelioma, it may be due to a company’s inability to protect and warn people against the dangers of asbestos.

 

Different states have different laws regarding mesothelioma cases.

 

Mesothelioma litigation procedures aren’t always the same. Different states have different rules and laws covering mesothelioma cases. One thing is common though, various localities have their own set specific time frames for litigation procedures. It is therefore very important that you seek legal assistance as soon as you have been diagnosed with mesothelioma. If you act too late, you may not be able to get the monetary compensation that is rightfully yours.

 

Not every lawyer can handle a mesothelioma case.

 

Any lawyer can handle a mesothelioma case. Not every lawyer however is ready or equipped to do so. Every lawyer has his/her own line of specialty. There are therefore some lawyers who know better how to handle a mesothelioma case. A mesothelioma lawyer would know better the legal technicalities, laws and details involved in a mesothelioma case. Other than these, he would also have sufficient disease knowledge to help clients trace exposure details and determine the extent of physical, emotional and financial damage.

 

Time is of the essence in a mesothelioma case. This does not mean though that you should be haphazard in your choice of a lawyer. Make sure that the expert that you pick has had some background and success in mesothelioma cases. A good lawyer can make the difference between prompt financial or emotional relief and absolute loss.

 

Litigation can be expensive.

 

Litigation of any kind can be costly. This is especially true for mesothelioma cases. Many legal entities however are aware that many clients are not able to pay outright. The collection of fees is therefore postponed until damages are awarded. Be warned though that attorney’s fees for mesothelioma cases can be quite steep. Lawyers can collect up to 40% of the total amount awarded. For many patients though this is already considered a fair deal. After all, mesothelioma cases are not easy to handle and win.

 

Mesothelioma litigation may not be easy. The compensation however, that you can hope to get after the procedure can be a great help to you and your family.